Healthcare - Biotechnology - NASDAQ - US
$ 10.8
-5.26 %
$ 739 M
Market Cap
-3.39
P/E
Price Target
Average
35.80%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
14.87%
Net Income
Estimate
15.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Replimune Group, Inc.
Wall Street analysts predict an average 1-year price target for REPL of $14.7 , with forecasts ranging from a low of $13 to a high of $17 .
REPL Lowest Price Target
Wall Street Target
13 USD
20.37%
REPL Average Price Target
Wall Street Target
14.7 USD
35.80%
REPL Highest Price Target
Wall Street Target
17 USD
57.41%
REVENUE FORECAST
Revenue Forecast Chart REPL
EBIT FORECAST
EBIT Forecast Chart REPL
NET INCOME FORECAST
Net Income Chart REPL